PCV31 HEALTH ECONOMIC ASSESSMENT OF RAISING HDL-C WITH PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) WHEN ADDED TO STATIN THERAPY IN PATIENTS WITH DYSLIPIDEMIA AND TYPE 2 DIABETES-AN ANALYSIS FOR SWEDEN
Abstract
Authors
C Renaudin D Liens AJ Palmer WJ Valentine W Berger S Roze